Pebblebrook Hotel Trust Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
53.6%projected annual EPS growth
Analyst Coverage
15analysts covering
FY EPS (est.)
-$0.31next fiscal year
Monitoring Framework
Key Performance Indicators
Same-Property RevPAR (Revenue per Available Room) Quarterly215.8Target: 2.0% to 4.75% growth for FY 2026
Same-Property Hotel EBITDA Margin Quarterly2,390.0%Target: Margin expansion driven by keeping property expense growth well controlled
Net Debt to Trailing 12-Month Corporate EBITDA Quarterly5.5Target: Continued leverage reduction from 5.9x at year-end 2025
Same-Property Hotel EBITDA Quarterly82.2MTarget: $366.5M to $378.5M for FY 2026 (revised post-Chamberlain sale)
Watch Items
- Urban Market Recovery (specifically San Francisco and Los Angeles)Trigger: Sustained double-digit RevPAR growth (Q1 2026 saw SF +44.5% and LA +31.5%)Action: Monitor quarterly segment disclosures and convention calendars to ensure demand momentum continues.
- Asset Dispositions and Capital RecyclingTrigger: Completion of non-core hotel sales at attractive private-market multiples (e.g., Chamberlain West Hollywood sold for $43.5M at 14.5x EBITDA)Action: Track the reallocation of proceeds toward debt reduction, preferred equity redemption, and opportunistic common share buybacks.
- Discretionary Leisure and Business Travel DemandTrigger: Shortening of booking windows or deceleration in weekday group/business transient demandAction: Evaluate forward booking pace and corporate group RFP trends during quarterly earnings calls.
Research as of 20 Jun 2026